Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on brain diseases, including both human and animal studies. Topics include, but are not limited to, stroke, traumatic brain injury, myelin disorders, epilepsy, multiple sclerosis, toxic encephalopathies, genetic diseases affecting the brain, alcohol and brain metabolism, neuroendocrinopathies, viral and nonviral encephalitides, nutritional disorders affecting the brain, diseases affecting neurotransmitters, Alzheimer's disease, Parkinson’s disease, amyotrophic lateral sclerosis and aging. The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies. Metabolic Brain Disease is directed to neuroscientists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of brain disorders.
Metabolic Brain Disease will consider Full Research Papers, Short Communications, Review Articles and Editorials. The journal is committed to high standards of presentation. Please contact the Editor to discuss the suitability of topics.
This is a transformative journal, you may have access to funding.
Guest Editor: Dr. Chong Gao (Zhejiang University City College, China)
Metabolic Brain Disease is assembling a series of Topical Collections highlighting some of the key research in the field. Four of these have now been published:
Early biomarker for neurodegenerative disorders
Edited by Dr. Sumit Sarkar (National Center for Toxicological Research, US Food and Drug Administration)
Neuronopathic lysosomal storage diseases
Edited by Prof. Grzegorz Węgrzyn (University of Gdansk)
Targeting pivotal dysregulated pathways in neurodegenerative diseases by natural products
Edited by Prof. Haroon Khan (Abdul Wali Khan University)
Modulation of mitochondrial physiology in neuroprotection and neurotoxicity
Edited by Prof. Marcos Roberto de Oliveira (Federal University of Mato Grosso)